Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
CP-945,598 is eliminated following extensive metabolism. Decrease hepatic function can affect
its elimination from the body via metabolism. This study will therefore compare the
pharmacokinetics (time course of drug concentrations in the body), safety, and tolerability
of CP-945,598 in patients with mild and moderate hepatic impairment and healthy control
subjects.